Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group.

Chest - 1 Oct 1994

Abstract excerpt

The Registry of Patients with Severe Deficiency of Alpha 1-Antitrypsin (A1AT) is a multicenter natural history study, with 37 participating clinical centers in the United States (36 centers) and Canada (1 center). The study has enrolled 1,129 individuals aged > or = 18 years with severe deficiency of A1AT (serum level < or = 11 microM), and will follow them longitudinally for up to 7 years, characterizing the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to Canada
Share to Data Collection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Longitudinal Studies

Share to Multicenter Studies as Topic

Share to Registries

Share to Respiratory Function Tests

Share to United States

Source

Identifiers

PMID: 7924498

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group.PMID 7924498Read ↗

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group.Semantic proximity Read ↗

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.Semantic proximity Read ↗

Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation.Semantic proximity Read ↗

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiencySemantic proximity Read ↗

Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.Semantic proximity Read ↗

Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency: a clinical-genetic overviewSemantic proximity Read ↗

[Alpha-1 antitrypsin deficiency].Semantic proximity Read ↗

Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development.Semantic proximity Read ↗

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.